Salta al contenuto principale

mitogen-activated protein kinase kinase kinase 1

The MAP3K1 gene provides instructions for making a protein that helps regulate signaling pathways that control various processes in the body, including the processes of determining sex characteristics before birth. The MAP3K1 protein attaches (binds) to other molecules called RHOA, MAP3K4, FRAT1, and AXIN1. The binding of MAP3K1 to these molecules, which are called cofactors, helps MAP3K1 control the activity of the signaling pathways.

Normal function

The MAP3K1 gene provides instructions for making a protein that helps regulate signaling pathways that control various processes in the body, including the processes of determining sex characteristics before birth. The MAP3K1 protein attaches (binds) to other molecules called RHOA, MAP3K4, FRAT1, and AXIN1. The binding of MAP3K1 to these molecules, which are called cofactors, helps MAP3K1 control the activity of the signaling pathways.

Conditions referring to this gene or chromosome

Altri nomi

M3K1_HUMAN

MAP/ERK kinase kinase 1

MAPK/ERK kinase kinase 1

MAPKKK1

MEK kinase 1

MEKK

MEKK 1

MEKK1

mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase

SRXY6

Related patient information and medicines

Distrofia muscolare

Patient information leaflet

Distrofia muscolare

Distrofia muscolare is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age they begin. If muscular dystrophy is suspected, tests can help to make an accurate diagnosis. Other.

Artrite idiopatica giovanile

Patient information leaflet

Artrite idiopatica giovanile

Juvenile idiopathic arthritis is a condition in which persisting joint inflammation first occur. Affected joints become painful and swollen, and can become damaged. Juvenile idiopathic arthritis cannot generally be cured but there are effective treatments... Options include: Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is.

Cancro primario al fegato

Patient information leaflet

Cancro primario al fegato

If you already have cirrhosis and your health becomes worse quite quickly, the cause may be a cancro al fegato which has developed. Everyone with cirrhosis should be having regular monitoring with an ultrasound and blood tests to detect any development of a liver cancer. There are new medicines being developed for the treatment of liver cancer. For.

Disordini di accumulo di glicogeno

Patient information leaflet

Disordini di accumulo di glicogeno

Disordini di accumulo di glicogeno are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Test di funzionalità epatica

Patient information leaflet

Test di funzionalità epatica

The pattern of the liver function tests can give a clue to the cause and can allow early detection of unsuspected problems, and monitoring of known problems. They include substances that are made in the liver or affected by the health of the liver cells, chemicals which are processed or excreted by the liver, and hormones that the liver makes in.

distrofia muscolare di Duchenne

Patient information leaflet

distrofia muscolare di Duchenne

distrofia muscolare di Duchenne is a condition which causes progressive muscle weakness. It starts in childhood and may be noticed when a child has difficulty standing up, climbing or running. What is Duchenne muscular dyst... Duchenne muscular dystrophy (DMD) è an inherited (genetic) condition which affects muscle strength and function. It causes.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 27 Ott 2023 | Ultima versione
  • 1 Mar 2015 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.